Mounjaro 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3USK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,689
Award facts
- Contract value 100% obligated
- $13,689.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp a delivery order valued at $13,689.02 on January 30, 2026, for the supply of Mounjaro 5 mg/0.5 mL pen injections. This is a firm fixed-price contract with an ultimate completion date of February 2, 2026, and was competitively awarded with no set-aside designation. The product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania. This delivery order represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026, which serves as a comprehensive pharmaceutical support vehicle for military healthcare programs worldwide.
Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as Amerisourcebergen), is a major pharmaceutical distributor that supplies critical medications and medical commodities to federal healthcare systems including the Defense Health Agency and U.S. Coast Guard. The company's extensive portfolio encompasses brand-name and generic pharmaceuticals, vaccines, and specialized medical supplies across multiple therapeutic domains. Mounjaro, a diabetes medication, aligns with the company's demonstrated capability to deliver specialized pharmaceutical products through competitive federal procurement processes.
Quick answers
Who was awarded contract SPE2DR26F3USK?
SPE2DR26F3USK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F3USK worth?
The government has obligated $13,689 on SPE2DR26F3USK.
Is contract SPE2DR26F3USK an order under another contract?
Yes. SPE2DR26F3USK is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3USK competed?
The extent of competition for SPE2DR26F3USK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award